Showing results (1-10 of 54) with videos related to

Sort By:
Pageof 6
Postepy Higieny I Medycyny Doswiadczalnej (Online)|August 1, 2009
[Peptides: a new class of anticancer drugs]Ryszard Smolarczyk, Tomasz Cichoń, Stanisław Szala
Postepy Higieny I Medycyny Doswiadczalnej (Online)|November 24, 2012
[HMGB1--its role in tumor progression and anticancer therapy]Ryszard Smolarczyk, Tomasz Cichoń, Magdalena Jarosz, et al.
Cytokine|March 8, 2005
Negligible induction of IFN-gamma, IL-12 and TNF-alpha by DNA-PEI 750 kDa/albumin complexesRyszard Smolarczyk, Tomasz Cichoń, Aleksander Sochanik, et al.
Postepy Higieny I Medycyny Doswiadczalnej (Online)|November 24, 2012
["Vicious circles" of glioblastoma tumors: vascularization and invasiveness]Stanisław Szala, Magdalena Jarosz, Ryszard Smolarczyk, et al.
Acta Biochimica Polonica|March 17, 2009
Combination of combretastatin A4 phosphate and doxorubicin-containing liposomes affects growth of B16-F10 tumorsIwona Mitrus, Aleksander Sochanik, Tomasz Cichoń, et al.
Acta Biochimica Polonica|October 5, 2002
Antiangiogenic gene therapy in inhibition of metastasisStanislaw Szala, Jaroslaw Szary, Tomasz Cichoń, et al.
International Journal of Molecular Sciences|July 3, 2019
Tumor Microenvironment as A "Game Changer" in Cancer RadiotherapyMagdalena Jarosz-Biej, Ryszard Smolarczyk, Tomasz Cichoń, et al.
European Journal of Pharmacology|November 1, 2020
Vascular disrupting agents in cancer therapyRyszard Smolarczyk, Justyna Czapla, Magdalena Jarosz-Biej, et al.
Acta Biochimica Polonica|December 5, 2006
Antitumor effect of RGD-4C-GG-D(KLAKLAK)2 peptide in mouse B16(F10) melanoma modelRyszard Smolarczyk, Tomasz Cichoń, Klaudyna Graja, et al.
Pageof 6